This research study is a randomized controlled study for a home-based, virtually supervised, aerobic exercise intervention for men with prostate cancer at high-risk of progression undergoing active surveillance. There is evidence that exercise may suppress cancer progression, but the evidence is preliminary.
Participants will be randomized into one of two treatment groups: Group A: Aerobic high-intensity interval training (HIIT) versus Group B: Waitlist Control. Randomization means a participant is placed into a study group by chance.
The research study procedures include screening for eligibility, study treatment visits, survey questionnaires, blood tests, and follow-up visits.
Participation in this research study is expected to last about 14 weeks.
It is expected that about 68 people will take part in this research study.
The Prostate Cancer Foundation is providing funding for this research study.
